Cost pressure and quality expectations on adverse drug event analysis are rising at the same time. Accreditation bodies assess event analysis on documented evidence of consistent practice. Participants finish able to explain this area of health and pharmaceutical services to a non-specialist audience without losing precision. What blocks progress on adverse drug event analysis is usually unclear ownership rather than unclear intent. Mature organisations treat this strand of health and pharmaceutical services as a standing capability rather than a project that finishes. It suits anyone whose decisions touch event analysis, in large organisations and small ones alike. The programme is built to be used, and every section of adverse drug event analysis it covers ends in something applicable. Each session closes with a decision the participant must justify about event analysis in their own setting. The closing exercise tests whether the participant's plan for the wider health and pharmaceutical services agenda survives a hostile question.
Expected Learning Outcomes
✓
Plan staffing and rota cover appropriate to demand in adverse drug event analysis.
✓
Establish incident and near-miss reporting on event analysis that staff trust.
✓
Set the minimum documentation for adverse drug event analysis that is genuinely necessary, and stop there.
✓
Audit event analysis in practice, not only in policy.
✓
Integrate adverse drug event analysis into existing management routines rather than running it separately.
✓
Document decisions about event analysis in a form that remains useful after the people change.
✓
Design a process for adverse drug event analysis that clinical staff can follow without obstructing care.
Who Should Attend
✓
Team leaders and supervisors who put adverse drug event analysis into practice day to day.
✓
Business partners who must understand event analysis well enough to challenge it.
✓
Accreditation and compliance officers preparing evidence on adverse drug event analysis.
✓
Quality and patient safety officers monitoring event analysis.
✓
Nursing managers and clinical supervisors delivering adverse drug event analysis.
✓
Supply chain and biomedical staff supporting event analysis.
Course Modules
Open any module to see its sessions and topics.
01
Adverse drug event analysis: staffing, capacity and demand
2 sessions · 8 points
Session 1Making incident reporting on adverse drug event analysis safe for staff
Agree the indicators that will show whether adverse drug event analysis is improving.
Identify where judgement in event analysis is legitimate and where it is not.
Define the trigger that would require adverse drug event analysis to be redesigned.
Identify single points of dependency in event analysis and reduce them.
Session 2Auditing event analysis at the bedside, not in the binder
Record the rationale for each significant choice made about adverse drug event analysis.
Assemble the accreditation evidence pack for event analysis.
Match staffing levels on adverse drug event analysis to measured demand across the week.
Select quality indicators for event analysis that measure outcome rather than activity.
02
Event analysis: infection prevention and patient safety
2 sessions · 8 points
Session 1Comparing event analysis with recognised practice
Map the clinical workflow for adverse drug event analysis as it is actually performed.
Write down the assumptions underpinning the approach to event analysis.
Collect evidence on the present handling of adverse drug event analysis before proposing changes.
Assign responsibility for keeping documentation of event analysis current.
Session 2Designing event analysis so it helps rather than obstructs care
Cost adverse drug event analysis per episode and identify avoidable waste.
Estimate the resource event analysis requires to run as designed.
Arrange the handover of adverse drug event analysis so capability survives staff changes.
Draft the minimum viable clinical protocol for event analysis.
03
Event analysis: clinical process design and workflow
2 sessions · 8 points
Session 1Building lasting competence in event analysis
Agree the smallest change to adverse drug event analysis that would be visibly useful.
Confirm the incident reporting route for event analysis is quick and non-punitive.
Measure patient experience of adverse drug event analysis and feed it back to the team.
Set out how exceptions to event analysis are requested and approved.
Session 2Investigating an adverse event involving adverse drug event analysis
Record what was learned when adverse drug event analysis did not go as planned.
Apply structured root cause analysis to the last adverse event involving event analysis.
Verify cold chain and storage conditions for materials used in adverse drug event analysis.
Confirm licensing and regulatory requirements applying to event analysis are met.
04
Event analysis: cost, efficiency and sustainability of the service
